| Dr Lori Nekota, PHARM D | |
|
6242 Forester Dr, Huntington Beach, CA 92648-6611 | |
| (714) 969-2412 | |
| (714) 969-1322 |
| Full Name | Dr Lori Nekota |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 6242 Forester Dr, Huntington Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003281239 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 040269 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lori Nekota, PHARM D 6242 Forester Dr, Huntington Beach, CA 92648-6611 Ph: (714) 969-2412 | Dr Lori Nekota, PHARM D 6242 Forester Dr, Huntington Beach, CA 92648-6611 Ph: (714) 969-2412 |
News Archive
Generex Biotechnology Corporation today announced that Bloomberg Television is scheduled to air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc.
New research published in the September issue of the Journal of the American College of Surgeons offers important insights into the long-term impact of a major disaster on routine surgical services in a hospital. In the study, researchers at Ochsner Health System, New Orleans, LA, showed that although Hurricane Katrina resulted in a significant loss of surgical staff and an increase in the number of uninsured patients undergoing operations, greater cost efficiencies were achieved.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease.
Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.
MAQUET Cardiovascular today announced the launch of its VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting (EVH) System, which utilizes next-generation HEMOPRO cut-and-seal technology to reduce thermal spread and to achieve optimal conduit quality for coronary artery bypass graft (CABG) surgery patients. The minimally invasive VASOVIEW HEMOPRO 2 system is an example of MAQUET Cardiovascular's commitment to EVH, and technologies that promote the highest level of conduit quality.
› Verified 2 days ago
Linda Lam, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15555 Huntington Village Ln Apt 183, Huntington Beach, CA 92647 Phone: 562-861-0479 | |
Jenee Vo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7562 Center Ave, Huntington Beach, CA 92647 Phone: 714-372-7511 | |
Thanh-thuy Thi Tran, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10114 Adams Ave, Huntington Beach, CA 92646 Phone: 714-593-3700 | |
Mrs. Grace Kim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8041 Newman Ave, Huntington Beach, CA 92647 Phone: 888-499-9303 | |
Tram Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18872 Beach Blvd, Huntington Beach, CA 92648 Phone: 714-378-1452 | |
Peter Choongsun Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6552 Bolsa Ave, Huntington Beach, CA 92647 Phone: 714-897-2541 Fax: 714-891-2041 |